DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 886 filers reported holding DANAHER CORPORATION in Q4 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $11,217,016 | +4.5% | 44,895 | +4.5% | 0.29% | +1.7% |
Q1 2024 | $10,730,468 | +27.8% | 42,970 | +18.4% | 0.29% | +11.2% |
Q4 2023 | $8,394,866 | +53.4% | 36,288 | +64.5% | 0.26% | +20.9% |
Q3 2023 | $5,472,093 | +22.6% | 22,056 | +18.6% | 0.22% | +15.0% |
Q2 2023 | $4,464,000 | +4.6% | 18,600 | +9.8% | 0.19% | -9.2% |
Q1 2023 | $4,268,802 | +6.0% | 16,937 | +11.7% | 0.21% | -15.2% |
Q4 2022 | $4,025,360 | +4.2% | 15,166 | +1.4% | 0.24% | -4.7% |
Q3 2022 | $3,864,000 | +8.7% | 14,959 | +6.7% | 0.26% | +18.1% |
Q2 2022 | $3,554,000 | -15.5% | 14,019 | -2.2% | 0.22% | -3.1% |
Q1 2022 | $4,206,000 | +26.3% | 14,338 | +41.7% | 0.22% | +14.9% |
Q4 2021 | $3,330,000 | +16.1% | 10,122 | +7.5% | 0.19% | +6.0% |
Q3 2021 | $2,867,000 | +6.4% | 9,416 | -6.2% | 0.18% | +12.3% |
Q2 2021 | $2,695,000 | +32.7% | 10,041 | +11.2% | 0.16% | +29.4% |
Q1 2021 | $2,031,000 | +2.2% | 9,026 | +0.9% | 0.13% | +4.1% |
Q4 2020 | $1,988,000 | +1.6% | 8,948 | -1.5% | 0.12% | -4.7% |
Q3 2020 | $1,957,000 | +20.7% | 9,088 | -0.9% | 0.13% | +7.6% |
Q2 2020 | $1,622,000 | +27.7% | 9,175 | 0.0% | 0.12% | +16.8% |
Q1 2020 | $1,270,000 | -9.8% | 9,175 | 0.0% | 0.10% | +17.4% |
Q4 2019 | $1,408,000 | +5.4% | 9,175 | -0.8% | 0.09% | +3.6% |
Q3 2019 | $1,336,000 | +1.0% | 9,250 | -0.0% | 0.08% | +5.1% |
Q2 2019 | $1,323,000 | +8.3% | 9,254 | 0.0% | 0.08% | +9.7% |
Q1 2019 | $1,222,000 | +122.2% | 9,254 | +73.5% | 0.07% | +105.7% |
Q4 2018 | $550,000 | -27.6% | 5,334 | -80.4% | 0.04% | -16.7% |
Q3 2018 | $760,000 | +46.2% | 27,194 | +416.4% | 0.04% | +40.0% |
Q2 2018 | $520,000 | -99.9% | 5,266 | -14.0% | 0.03% | -6.2% |
Q1 2018 | $599,308,000 | +21.5% | 6,121 | +15.2% | 0.03% | +28.0% |
Q4 2017 | $493,152,000 | +8.2% | 5,313 | 0.0% | 0.02% | 0.0% |
Q3 2017 | $455,749,000 | +1.7% | 5,313 | +0.0% | 0.02% | 0.0% |
Q2 2017 | $448,279,000 | +11.2% | 5,312 | +12.7% | 0.02% | +4.2% |
Q1 2017 | $403,018,000 | +9.9% | 4,712 | 0.0% | 0.02% | +4.3% |
Q4 2016 | $366,782,000 | -14.3% | 4,712 | -13.7% | 0.02% | -17.9% |
Q3 2016 | $428,166,000 | +5.8% | 5,462 | +36.3% | 0.03% | 0.0% |
Q2 2016 | $404,707,000 | -40.3% | 4,007 | -43.9% | 0.03% | -40.4% |
Q1 2016 | $677,490,000 | +94.8% | 7,142 | +76.0% | 0.05% | +88.0% |
Q4 2015 | $347,725,000 | -17.3% | 4,057 | -17.8% | 0.02% | -13.8% |
Q3 2015 | $420,682,000 | +19.0% | 4,937 | +19.5% | 0.03% | +45.0% |
Q2 2015 | $353,658,000 | +2.7% | 4,132 | +1.8% | 0.02% | 0.0% |
Q1 2015 | $344,439,000 | -0.9% | 4,057 | 0.0% | 0.02% | 0.0% |
Q4 2014 | $347,725,000 | +18.7% | 4,057 | +5.2% | 0.02% | +11.1% |
Q3 2014 | $293,055,000 | -67.7% | 3,857 | -66.5% | 0.02% | -66.0% |
Q2 2014 | $906,733,000 | +2.4% | 11,517 | -2.5% | 0.05% | -3.6% |
Q1 2014 | $885,525,000 | -14.9% | 11,807 | -12.4% | 0.06% | -19.1% |
Q4 2013 | $1,040,038,000 | +11.6% | 13,472 | +0.2% | 0.07% | -1.4% |
Q3 2013 | $932,146,000 | +2.5% | 13,447 | -6.4% | 0.07% | -5.5% |
Q2 2013 | $909,115,000 | – | 14,362 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |